Litcius/Paper detail

Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review

Juan Du, Yonghong Zhang

2020Journal of Cancer Research and Clinical Oncology38 citationsDOIOpen Access PDF

Topics & Concepts

MedicineChimeric antigen receptorCytokine release syndromeLymphomaInternal medicineCD20ImmunotherapyChemotherapyRefractory (planetary science)OncologyHematologyImmunologyCD19AntigenGastroenterologyCancerBiologyAstrobiologyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders research
Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review | Litcius